Celltrion (068270.KS) Q2: Margin 33%, Record ₩430B Profit
Celltrion (068270.KS), Korea's largest biosimilar maker, said its second-quarter operating margin leapt to roughly 33% — the sharpest profitability move in the
- 02
Hanall Biopharma (009420.KS) Q1 2026: Operating Loss Flips to ₩840M Profit as Clinical Debt Surges 79%
Hanall Biopharma (009420) posts Q1 2026 operating profit of ₩840M, revenue +10.7% YoY. Short-term borrowings surge 79% ahead of Phase 3 clinical readouts.
- 03
KOSPI Sinks 7.9% as 'Meta Shock' Routs Korean Chip Stocks
KOSPI plunged 7.89% to 7,648.09 on July 2, 2026 as Meta's AI cloud plans sparked fears of AI compute overcapacity, sending SK Hynix down 14.57% and Samsung down 9.06% in a 'Black Thursday' rout.
- 04
Seoul and Washington Clash Over ₩624.7B Coupang Fine as US House Labels Korea's Data Enforcement Discriminatory
South Korea's Foreign Ministry and NIS push back against a US House Judiciary Committee report that labels the PIPC's record ₩624.7 billion ($403 million) privacy fine against Coupang as 'discriminatory.' The fine stems from a Chinese-employee data breach exposing 37 million Coupang users.
- 05
Google's €4.1B EU Fine Sealed, Samsung (005930.KS) in Focus
On July 2, the Court of Justice of the European Union (the EU's highest court, whose rulings cannot be appealed) dismissed the final challenge from Alphabet's G
- 06
F&F (383220.KS) Q1 2026: ₩104.2B Property Gain Doubles Net Income; Core Operating Profit Up 24%
F&F (383220.KS) Q1 2026: ₩104.2B Property Gain Doubles Net Income; Core Operating Profit Up 24%
- 07
Hanmi Pharma (128940.KS) Promotes Obesity, Licensing VPs
Hanmi Group, a Korean pharmaceutical group whose listed drugmaker Hanmi Pharmaceutical (128940.KS) is a KOSPI large-cap, on July 2 promoted six executives in it
- 08
SK Hynix Pledges ₩100 Trillion ($64B) for New Memory Capacity
SK Hynix CEO announces ₩100 trillion ($64B) Cheongju investment: ₩80T for NAND fab M17 (2029) and ₩20T for advanced HBM packaging (2027), as KOSPI fell 4.46% on AI capex fears.
- 09
iM Financial Group (139130.KS) Q1 2026: ₩154.5B Profit Flat as Provisions Surge 26%
iM Financial Group Q1 2026: ₩154.5B net profit (+0.1% YoY), operating income fell 7.3% to ₩193.9B as provisions surged 26.3%. iM Bank total assets crossed ₩105 trillion.
- 10
Hanmi Semiconductor Chairman Buys ₩5B Stock Before HBM4 Ramp
Hanmi Semiconductor Chairman Kwak Dong-shin adds ₩5B in personal stock purchases, bringing three-year total to ₩69.5B, signaling conviction in TC Bonder demand ahead of HBM4 ramp.
- 11
BYD's First Korea Recall Part of 146,505-Vehicle Sweep
South Korea orders 146,505-vehicle recall. BYD faces first-ever Korean recall; Hyundai Tucson leads volume at 54,792 units.
LineVest Daily
Get this wrap in your inbox every morning.
One email before the U.S. open — the earnings, filings, and guidance changes that matter, in plain English. Free.
Subscribe free